Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed CFO
Quarterly results
Director departure
CC transcript
Anika Therapeutics, Inc. (ANIK) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 SC 13D Caligan Partners LP reports a 6.2% stake in Anika Therapeutics, Inc.
08/08/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Anika Reports Second Quarter 2023 Financial Results"
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Anika Reports First Quarter 2023 Financial Results Positive Start to 2023 Revenue Growth with OA Pain Management Up 8% and Joint Preservation and Restoration Up 11%"
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/28/2023 8-K Quarterly results
04/25/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
04/13/2023 8-K Quarterly results
04/05/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
03/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/27/2023 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/06/2023 8-K Quarterly results
Docs: "Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A DIMENSIONAL FUND ADVISORS LP reports a 6.6% stake in Anika Therapeutics Inc
02/10/2023 SC 13G/A Trigran Investments, Inc. reports a 10.7% stake in ANIKA THERAPEUTICS, INC.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 6.7% stake in Anika Therapeutics Inc.
02/08/2023 SC 13G/A STATE STREET CORP reports a 6.2% stake in AMENDED FILING ANIKA THERAPEUTICS INC
01/20/2023 SC 13G BlackRock Inc. reports a 17.3% stake in ANIKA THERAPEUTICS INC
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
10/06/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/04/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
Docs: "Anika Reports Second Quarter Fiscal 2022 Financial Results"
06/10/2022 8-K Quarterly results
06/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/03/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/01/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy